Natural history and cycle threshold values analysis of COVID-19 in Xiamen City, China.

Bin Deng, Weikang Liu, Zhinan Guo, Li Luo, Tianlong Yang, Jiefeng Huang, Buasiyamu Abudunaibi, Yidun Zhang, Xue Ouyang, Demeng Wang, Chenghao Su, Tianmu Chen
Author Information
  1. Bin Deng: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  2. Weikang Liu: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  3. Zhinan Guo: Xiamen Center for Disease Control and Prevention, Xiamen City, Fujian Province, People's Republic of China.
  4. Li Luo: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  5. Tianlong Yang: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  6. Jiefeng Huang: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  7. Buasiyamu Abudunaibi: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.
  8. Yidun Zhang: Xiamen Center for Disease Control and Prevention, Xiamen City, Fujian Province, People's Republic of China.
  9. Xue Ouyang: Xiamen Center for Disease Control and Prevention, Xiamen City, Fujian Province, People's Republic of China.
  10. Demeng Wang: Xiamen Center for Disease Control and Prevention, Xiamen City, Fujian Province, People's Republic of China.
  11. Chenghao Su: Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen City, Fujian Province, People's Republic of China.
  12. Tianmu Chen: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.

Abstract

Objective: This study elaborated the natural history parameters of Delta variant, explored the differences in detection cycle thresholds (Ct) among cases.
Methods: Natural history parameters were calculated based on the different onset time and exposure time of the cases. Intergenerational relationships between generations of cases were calculated. Differences in Ct values of cases by gender, age, and mode of detection were analyzed statistically to assess the detoxification capacity of cases.
Results: The median incubation period was 4 days; the detection time for cases decreased from 25 to 7 h as the outbreak continued. The average generation time (GT), time interval between transmission generations (TG) and serial interval (SI) were 3.6 ± 2.6 days, 1.67 ± 2.11 days and 1.7 ± 3.0 days. Among the Ct values, we found little differences in testing across companies, but there were some differences in the gender of detected genes. The Ct values continuous to decreased with age, but increased when the age was greater than 60.
Conclusion: This epidemic was started from aggregation of factories. It is more reasonable to use SI to calculate the effective reproduction number and the time-varying reproduction number. And the analysis of Ct values can improve the positive detection rate and improve prevention and control measures.

Keywords

References

  1. N Engl J Med. 2020 Mar 26;382(13):1199-1207 [PMID: 31995857]
  2. Math Biosci Eng. 2020 May 11;17(4):3512-3519 [PMID: 32987541]
  3. J Med Virol. 2021 May;93(5):3007-3014 [PMID: 33527470]
  4. J Med Virol. 2020 Sep;92(9):1695-1698 [PMID: 32383179]
  5. N Engl J Med. 2020 May 28;382(22):2081-2090 [PMID: 32329971]
  6. J Med Virol. 2021 Dec;93(12):6794-6797 [PMID: 34264527]
  7. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1167-1169 [PMID: 34437521]
  8. Monaldi Arch Chest Dis. 2021 Jul 21;91(4): [PMID: 35104932]
  9. Expert Rev Clin Immunol. 2020 Dec;16(12):1159-1184 [PMID: 33356661]
  10. Euro Surveill. 2020 Aug;25(32): [PMID: 32794447]
  11. BMC Infect Dis. 2021 Mar 11;21(1):257 [PMID: 33706702]
  12. Proc Biol Sci. 2007 Feb 22;274(1609):599-604 [PMID: 17476782]
  13. J Korean Med Sci. 2020 Dec 28;35(50):e435 [PMID: 33372427]
  14. EClinicalMedicine. 2021 Oct;40:101129 [PMID: 34541481]
  15. China CDC Wkly. 2021 Aug 20;3(34):716-719 [PMID: 34594975]
  16. Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392 [PMID: 33031141]
  17. Vaccines (Basel). 2021 Nov 02;9(11): [PMID: 34835198]
  18. Viruses. 2021 Feb 11;13(2): [PMID: 33670360]
  19. Int J Environ Res Public Health. 2020 Oct 17;17(20): [PMID: 33080869]
  20. J Korean Med Sci. 2020 Jun 01;35(21):e199 [PMID: 32476305]
  21. Science. 2020 Jun 26;368(6498):1481-1486 [PMID: 32350060]
  22. Infect Dis Poverty. 2020 Aug 26;9(1):117 [PMID: 32843094]
  23. Lancet Public Health. 2021 Mar;6(3):e175-e183 [PMID: 33484644]
  24. Emerg Infect Dis. 2022 Jun;28(6):1224-1228 [PMID: 35393009]
  25. Int J Infect Dis. 2020 Apr;93:284-286 [PMID: 32145466]
  26. PLoS Pathog. 2022 Mar 25;18(3):e1010181 [PMID: 35333914]
  27. Clin Infect Dis. 2020 Nov 19;71(16):2252-2254 [PMID: 32435816]
  28. J Infect Public Health. 2020 Dec;13(12):1823-1829 [PMID: 32896496]
  29. Front Med (Lausanne). 2021 Aug 18;8:701836 [PMID: 34485337]
  30. BMJ. 2020 Apr 21;369:m1443 [PMID: 32317267]
  31. PLoS One. 2021 Aug 12;16(8):e0254798 [PMID: 34383766]
  32. J Neuroimmune Pharmacol. 2020 Sep;15(3):359-386 [PMID: 32696264]

Word Cloud

Created with Highcharts 10.0.0casesCttimevalueshistorydetectiondaysdifferencesNaturalageparameterscyclecalculatedgenerationsgenderdecreasedintervalSI1reproductionnumberanalysisimprovethresholdCOVID-19Objective:studyelaboratednaturalDeltavariantexploredthresholdsamongMethods:baseddifferentonsetexposureIntergenerationalrelationshipsDifferencesmodeanalyzedstatisticallyassessdetoxificationcapacityResults:medianincubationperiod4257 houtbreakcontinuedaveragegenerationGTtransmissionTGserial36 ± 2667 ± 2117 ± 30Amongfoundlittletestingacrosscompaniesdetectedgenescontinuousincreasedgreater60Conclusion:epidemicstartedaggregationfactoriesreasonableusecalculateeffectivetime-varyingcanpositiveratepreventioncontrolmeasuresXiamenCityChinaCyclevalue

Similar Articles

Cited By